TCL Archive Segmental Study Finally Published, Says Less Surgery as Good as More, Radiation Helped March 22, 1985
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: The Anatomy Of An Administrative Nightmare: How NIH Spent $518 Million In One Day October 23, 1992
TCL Archive FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization January 28, 2011
